Radiopharm Theranostics Ltd Share

Radiopharm Theranostics Ltd (RADX) is a biopharmaceutical company focused on developing a pipeline of novel radiopharmaceutical products for diagnostic and therapeutic applications. The company operates within the healthcare sector, specifically targeting unmet needs in oncology. Radiopharm's approach involves utilizing targeted radiopharmaceuticals to detect and treat cancer cells with precision, potentially improving patient outcomes and minimizing side effects. Their research and development efforts encompass a range of cancer types, aiming to provide innovative solutions for early detection, personalized treatment strategies, and improved monitoring of disease progression. By leveraging the power of radiotheranostics, Radiopharm seeks to transform cancer care and enhance the lives of patients worldwide. The company is listed on the NASDAQ exchange.